FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On January 9, 2004
Table of Contents
Docket # Title
1995N-0309 CGMPs for the Production of Infant Formula
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
1998P-1194 Withdrawal NADA Approval for Posilac - rBGH
2000P-0685 Revise of Yogurt Standards
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
2002N-0058 Pediculicide Drug Products for OTC Human Use
2002N-0277 Bioterrorism; Establishment & Maintenance of Records
2002N-0278 Bioterrorism; Prior Notice of Imported Food Shipments
2002P-0489 Request Revision of CVM's Bioequivalence Guidelines
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
2003D-0504 Bundling Multiple Devices in a Single Application; Draft Guidance for Industry and FDA; Availability
2003D-0562 Compliance Policy Guide Sec.110.300 b
2003P-0362 Over-the-counter Hearing Aids
2003P-0530 Silicone Gel-filled Breast Implants
2004P-0013 Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
2004P-0015 Deny approval of any New Drug Application ( NDA ) for recombinant salmon calcitonin (rsCT ) nasal spray
1995N-0309 CGMPs for the Production of Infant Formula
C 26 American Academy of Pediatrics (AAP) Vol #: 9
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 12202 New Chapter, Inc. Vol #: 97
LET 12203 New Chapter, Inc. Vol #: 97
LET 12204 New Chapter, Inc. Vol #: 97
LET 12205 Solstice Medicine Company Vol #: 97
LET 12206 Solstice Medicine Company Vol #: 97
LET 12207 Solstice Medicine Company Vol #: 97
LET 12208 Solstice Medicine Company Vol #: 97
LET 12209 Solstice Medicine Company Vol #: 97
LET 12210 Solstice Medicine Company Vol #: 97
LET 12211 Solstice Medicine Company Vol #: 97
LET 12212 Solstice Medicine Company Vol #: 97
LET 12213 Solstice Medicine Company Vol #: 97
LET 12214 Source Naturals Vol #: 97
LET 12215 Source Naturals Vol #: 97
LET 12216 Source Naturals Vol #: 97
LET 12217 Solstice Medicine Company Vol #: 97
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 7335 Jan & Jim Leschke Vol #: 305
C 7336 Rabbi T. Feldman Vol #: 305
C 7337 T. Tyler Vol #: 305
C 7338 K.L. Ohanyan Vol #: 305
C 7339 Farm Sanctuary Vol #: 305
C 7340 R. & R. Getz Vol #: 305
C 7341 F.S. Platen Vol #: 305
C 7342 C.R. Pendergrass Vol #: 305
C 7343 G.A. Kerwin Vol #: 305
C 7344 C. Girvan Vol #: 305
C 7345 A. Stoll Vol #: 305
C 7346 M. MacDonald Vol #: 305
C 7347 G.H. Birk Vol #: 305
C 7348 E. Adams Vol #: 305
C 7349 J. Emich Vol #: 305
C 7350 Teen Animal Protectors Vol #: 305
C 7351 E.H. Swan Vol #: 305
C 7352 A. Panzer Vol #: 305
1998P-1194 Withdrawal NADA Approval for Posilac - rBGH
C 872 K. Walters Vol #: 43
C 873 L. Burgess Vol #: 43
C 874 M. Cottrell Vol #: 43
C 875 A. Evans Vol #: 43
C 876 M. Gallace Vol #: 43
C 877 J. Kaltenmeier Vol #: 43
2000P-0685 Revise of Yogurt Standards
C 12 P. Halloran Vol #: 1
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
C 324 J. Anderson Vol #: 125
C 325 A. Anderson Vol #: 125
C 326 Sexual Assault and Violence Intervention Program (SAVI) Vol #: 125
C 327 State of Washington Dept of Health Vol #: 125
C 328 S. Dubinsky Vol #: 125
C 329 Operation Outcry: Silent No More Vol #: 125
C 330 G. Mueller Vol #: 125
C 331 B. Boone Vol #: 125
C 332 M. O'Dell Vol #: 125
C 333 American Academy of Family Physicians Vol #: 125
C 334 M.L. Palazzo Vol #: 125
C 335 Form Letter Vol #: 126
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
C 1354 C. Cogle Vol #: 233
2002N-0058 Pediculicide Drug Products for OTC Human Use
SUP 1 Supplemental Material Vol #: 1
2002N-0277 Bioterrorism; Establishment & Maintenance of Records
C 105 Comite Interprofessionnel Du Vin de Champagne Vol #: 16
C 106 Fountain fruit Corporation Vol #: 16
2002N-0278 Bioterrorism; Prior Notice of Imported Food Shipments
C 287 Department of Defense (DoD) Vol #: 22
2002P-0489 Request Revision of CVM's Bioequivalence Guidelines
PDN 1 HFC-1 to James H. Schafer, D.V.M. Vol #: 1
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
C 56 Form Letters Vol #: 4
C 57 ECR Pharmaceuticals Vol #: 5
C 58 T. Kerr Vol #: 5
C 59 Adams Laboratories, Inc. Vol #: 4
C 60 Healthpoint, Ltd Vol #: 5
2003D-0504 Bundling Multiple Devices in a Single Application; Draft Guidance for Industry and FDA; Availability
C 1 Olympus America, Inc. Vol #: 1
2003D-0562 Compliance Policy Guide Sec.110.300 b
C 1 M.L. Sotelo Vol #: 1
2003P-0362 Over-the-counter Hearing Aids
C 7 Tru Hearing Vol #: 1
2003P-0530 Silicone Gel-filled Breast Implants
C 2 Action Against Silicone Gel-UK Vol #: 1
C 3 Secretary Dutch Silicone Support Group,St.SVS Vol #: 1
2004P-0013 Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
ACK 1 HFA-305 to Consumer Vol #: 1
CP 1
Attachment 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Consumer Vol #: 1
2004P-0015 Deny approval of any New Drug Application ( NDA ) for recombinant salmon calcitonin (rsCT ) nasal spray
ACK 1 HFA-305 to Buc & Beardsley Vol #: 1
CP 1 Buc & Beardsley Vol #: 1

Page created on January 15, 2004 kk
Page updated on January 28, 2004

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management